Dropwort-induced metabolic reprogramming restrains YAP/TAZ/TEAD oncogenic axis in mesothelioma

Abstract

Background Over the past decade, newly designed cancer therapies have not significantly improved the survival of patients diagnosed with Malignant Pleural Mesothelioma (MPM). Among a limited number of genes that are frequently mutated in MPM several of them encode proteins that belong to the HIPPO tumor suppressor pathway. Methods The anticancer effects of the top flower standardized extract of Filipendula vulgaris (Dropwort) were characterized in “in vitro” and “in vivo” models of MPM. At the molecular level, two “omic” approaches were used to investigate Dropwort anticancer mechanism of action: a metabolomic profiling and a phosphoarray analysis. Results We found that Dropwort significantly reduced cell proliferation, viability, migration and in vivo tumor growth of MPM cell lines. Notably, Dropwort affected viability of tumor-initiating MPM cells and synergized with Cisplatin and Pemetrexed in vitro. Metabolomic profiling revealed that Dropwort treatment affected both glycolysis/tricarboxylic acid cycle as for the decreased consumption of glucose, pyruvate, succinate and acetate, and the lipid metabolism. We also document that Dropwort exerted its anticancer effects, at least partially, promoting YAP and TAZ protein ubiquitination. Conclusions Our findings reveal that Dropwort is a promising source of natural compound(s) for targeting the HIPPO pathway with chemo-preventive and anticancer implications for MPM management. Electronic supplementary material The online version of this article (10.1186/s13046-019-1352-3) contains supplementary material, which is available to authorized users.

Oral mucositis: the hidden side of cancer therapy

“…Accordingly, they are often well tolerated by patients and do not induce severe adverse events. Moreover, thanks to their chemical structure, they can concurrently impinge Lactobacillus Probiotic Preserves mucosal intestinal architecture [106,107] on several cellular signaling pathways thus affecting mucositis pathogenesis process at different levels, as well as negatively impacting on tumorigenic activities of cancer cells [109,111,112]. Actually, diverse natural products have been already tested and others are under investigation in active clinical trials.…”

Artichoke phytocomplex modulates serum microRNAs in patients exposed to asbestos: a first step of a phase II clinical trial

“…The in-silico analysis revealed that several targets triggered by miRNA-181a-5p and 193a-5p were involved in mesothelioma development. In particular, we found proteins involved in the regulation of pathways aberrantly activated in mesothelioma, such as MAPK, PI3K-Akt and mTOR signalling pathways [ 4 , 11 , 12 ], as well as the EGFR [ 13 ], Hippo [ 14 , 15 ], epithelial to mesenchymal transition [ 16 ] and NF-kappa B signalling pathways [ 17 , 18 ]. While miRNA-181-5p exerts an inhibitor regulation on those pathways, thereby eliciting a tumor-suppressor effect, miRNA 193-5p had an inverse role.…”

Molecular Alterations in Malignant Pleural Mesothelioma: A Hope for Effective Treatment by Targeting YAP

“…Unfortunately, verteporfin exhibits many undesirable effects that prevent its use in clinical practice. Another study showed that using the extract from the top flower of a medicinal plant, Dropwort, restrains the oncogenic activity of both YAP and TAZ through promoting ubiquitination in both “in vitro” and “in vivo” MPM models [ 261 ]. Additionally, peptide inhibitors that disrupt the interaction between TEAD and YAP/TAZ could represent a potential therapeutic option, as recently shown in gastric cancer [ 262 ].…”